These data demonstrate that SHP2 has a critical time-dependent role in modulating the proliferation and chondrocytic differentiation of OCPs and that aberrant SHP2 signaling in OCPs can lead to neoplastic cell growth and cartilage tumor formation at certain developmental stages. Here, PTPN11 is linked to neoplasm.